As of 2024-07-27, the Relative Valuation of Theravance Biopharma Inc (TBPH) is (6.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.25 USD, the upside of Theravance Biopharma Inc based on Relative Valuation is -166.5%.
The range of the Relative Valuation is (7.14) - (7.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.4x - 8.2x | 6.5x |
| Forward P/E multiples | 7.8x - 8.7x | 8.3x |
| Fair Price | (7.14) - (7.59) | (6.81) |
| Upside | -169.7% - -174.0% | -166.5% |
| Date | P/E |
| 2024-07-26 | -11.13 |
| 2024-07-25 | -11.09 |
| 2024-07-24 | -10.86 |
| 2024-07-23 | -10.95 |
| 2024-07-22 | -11.12 |
| 2024-07-19 | -10.39 |
| 2024-07-18 | -10.51 |
| 2024-07-17 | -10.74 |
| 2024-07-16 | -10.85 |
| 2024-07-15 | -10.72 |
| 2024-07-12 | -10.18 |
| 2024-07-11 | -10.13 |
| 2024-07-10 | -9.58 |
| 2024-07-09 | -9.69 |
| 2024-07-08 | -9.60 |
| 2024-07-05 | -9.51 |
| 2024-07-03 | -9.24 |
| 2024-07-02 | -9.04 |
| 2024-07-01 | -9.25 |
| 2024-06-28 | -9.21 |
| 2024-06-27 | -9.05 |
| 2024-06-26 | -9.13 |
| 2024-06-25 | -9.12 |
| 2024-06-24 | -9.53 |
| 2024-06-21 | -9.50 |
| 2024-06-20 | -9.41 |
| 2024-06-18 | -9.21 |
| 2024-06-17 | -9.16 |
| 2024-06-14 | -9.21 |
| 2024-06-13 | -9.32 |
| 2024-06-12 | -9.38 |
| 2024-06-11 | -9.58 |
| 2024-06-10 | -9.45 |
| 2024-06-07 | -9.53 |
| 2024-06-06 | -9.64 |
| 2024-06-05 | -9.75 |
| 2024-06-04 | -9.37 |
| 2024-06-03 | -9.26 |
| 2024-05-31 | -9.36 |
| 2024-05-30 | -9.22 |
| 2024-05-29 | -9.00 |
| 2024-05-28 | -9.13 |
| 2024-05-24 | -9.06 |
| 2024-05-23 | -9.29 |
| 2024-05-22 | -9.75 |
| 2024-05-21 | -9.91 |
| 2024-05-20 | -9.88 |
| 2024-05-17 | -10.09 |
| 2024-05-16 | -10.43 |
| 2024-05-15 | -10.70 |